Drug Co. Founders Defend Legal Fees In $20M Chancery Suit
Company-paid legal fee rights should be read broadly in the case of two controlling biotech company investors and directors facing a $20 million fraud and fiduciary breach suit in California, an...To view the full article, register now.
Already a subscriber? Click here to view full article